We are leaders in genomic software and precision medicine. Our solutions enable clinicians to identify the best treatment options and provide fast, effective, targeted therapies for cancer patients. Our products are used in more than 2,000 laboratories and 100 hospitals around the world.
“Strand Life Sciences has been a leader in genomic analysis for years. It is wonderful to see them bring their expertise into Personalized Medicine, where they can help physicians to effectively tailor therapies to the genomic profiles of their patients and their tumors.“
Adam Bass, MD
Dana-Farber Cancer Institute
Our testing process is designed to provide you with fast, actionable treatment options so you can begin targeted therapies as quickly as possible. If you have questions, our client services team is here to provide support every step of the way.
Collect the tumor sample using the kits that we provide and mail to Strand in a prepaid mailing packet that is overnighted to our laboratory.
We process the samples through our state-of-the-art analysis, interpretation, and reporting platforms. The 8-gene Bridge test is delivered in eight days and is followed by the full StrandAdvantage results two weeks later.
Receive your clinical report through a secure physician portal. The final results are delivered in an easy-to-read report containing actionable genomic variant information. Complimentary clinical consultations are available upon request.